{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011634","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.810106+00:00","generated_at":"2026-05-17T19:39:17.797252+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"INBS submits FDA 510(k) AI response; expects clearance decision within six weeks","bullets":["Submitted over 1,900 pages including 23 detailed test reports and 7,800 data lines from 10,000 hours of testing.","New cybersecurity and performance data reinforce fingerprint sweat drug screening platform for U.S. market entry in 2025.","Company serves 450+ accounts in 24 countries with 18 global distribution partners.","FDA response anticipated within six weeks.","CEO calls U.S. market entry a top priority given multi-billion-dollar commercial opportunity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011634","json":"https://secwatch.observer/filing/0001493152-25-011634.json","markdown":"https://secwatch.observer/filing/0001493152-25-011634.md","text":"https://secwatch.observer/filing/0001493152-25-011634.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225011634/0001493152-25-011634-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225011634/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:39:17.797252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}